Skip to main content
. 2020 Mar 10;14:1057–1081. doi: 10.2147/DDDT.S237252

Figure 3.

Figure 3

The substructure-combinational strategy is used for producing potent and selective ATTR inhibitors (A). The binding model is indicated within the T4-binding pockets (B). The indicated structure may be considered as the possible pharmacophoric elements (C), and the alternative substitutions may be showed as Z, Y, and X.